Back to Screener

Healthcare

COSMOS Pharmaceutical Corporation(CSMYF)

Live Price

Offline

$37.06

+0.00% today

1Y Change

-19.54%

Window

Jun 27, 2025 โ†’ Jun 23, 2026

Market Cap
$488.86B
Revenue Growth
+4.8%
EPS Growth
+26.7%
Dividend Yield
1.2%

Coverage: 151 bars ยท Jun 27, 2025 โ†’ Jun 23, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

COSMOS Pharmaceutical Corporation (CSMYF) is a Healthcare stock with a market cap of $488.86B. The stock last traded around $37.06 and down 19.5% across the available one-year price window (Jun 27, 2025 โ†’ Jun 23, 2026). Baseline metrics include revenue growth of +4.8%, EPS growth of +26.7%, a dividend yield of 1.2%. What stands out right now is revenue +4.8%, EPS +26.7%, free cash flow -35.3% with operating margin 3.8% and ROIC 8.9%. The dividend is present but secondary, with a yield around 1.2%. Valuation is more restrained than many high-expectation growth names at P/E 15.6 and price/sales 0.5. Stock Foundry combines CSMYF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.

Benchmark Edge

CSMYF vs SPY, QQQ, and Sector ETFs

Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.

Shared 1Y chart + MAX history table

CSMYF

โ€”

Normalized return

SPY

--

S&P 500

Excess Return

--

Relative to SPY

CSMYF Max Drawdown

-23.23%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for CSMYF and SPY.

Calendar-year return history is still loading or unavailable.

Earnings Reports

๐Ÿ“… Last reportedApr 12, 2026Q2
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”Report
Q2
Apr 12, 26
โ€”
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Apr 12
Q1
Jan 7, 26
โ€”
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Jan 7
Q4
Oct 8, 25
โ€”
Est โ€”
โ€”
โ€”
Est โ€”
โ€”
Oct 8
Q1
Jan 12, 23
โœ—
121.67
Est 132.11
-7.9%
โ€”
Est โ€”
โ€”
Jan 12
Q4
Oct 10, 22
โœ“
163.67
Est 155.96
+4.9%
โ€”
Est โ€”
โ€”
Oct 10
No upcoming earnings in the next 90 days

Next Step

Connect reports to catalysts

Earnings pages get much more useful when they are tied back to upcoming dates, expectations, and peer setups.